Work with us
Your partner in developing the next generation of precision oncology therapies.
Advanced therapeutic development strategies
De-risk development by embedding Strata testing as an exploratory/proactive biomarker strategy, re-evaluate and rescue failed trials through retrospective testing, or target novel, highly responsive patient populations to differentiate your pipeline.
Post-approval expansion
Access a rapid, cost-effective pathway for identifying more patients who could benefit from existing therapies in the Strata PATH trial. Biomarker-guided individual or pan-tumor indications not currently in your pipeline can be targeted.
Clinical trial matching
Accelerate new oncology drug approvals by identifying potential participants for your trials from our testing.
Central lab testing
Use our platform for efficient and standardized testing of samples from your chosen sites to identify patients with target alterations.